IV Medications Elsevier 5.4.1

IV Medications Elsevier 5.4.1

Skyscape Medpresso Inc – Freeware – iOS
68 oy
Son Sürüm
5.4.1
image/svg+xml EXCELLENT User Rating

"Try before you buy" - Download the FREE App, which includes sample content. In-App purchase required to unlock all content.

Discover the leading IV drug handbook for administering over 400 intravenous drugs safely! Elsevier's Intravenous Medications: A Handbook for Nurses and Health Professionals has been a trusted resource for accurate and complete drug information in a concise format for nearly 50 years. In the 2024 edition, you'll find updated drug uses, interactions, precautions, alerts, and patient teaching instructions for all current IV drugs. Plus, we've added 8 monographs featuring the most recently FDA-approved IV drugs. This annual publication is the #1 choice for critical care areas, nursing stations, offices, and public health and home care settings.

Key Features:

  • Detailed monographs on over 400 IV drugs offer comprehensive coverage surpassing any other drug reference.
  • Each monograph includes the drug name, phonetic pronunciation, usual dose, dilution, compatibility, rate of administration, actions, indications and uses, contraindications, precautions, interactions, side effects, antidote, and more.
  • Additional drug monographs can be found on the Evolve website.
  • Highlighted Black Box Warnings allow for easy identification of medications with serious safety risks.
  • Blue-screened text draws attention to special circumstances not covered by Black Box Warnings.
  • Dosage and dilution charts within each monograph provide quick summaries of essential clinical information.
  • Life-stage dosage variances are highlighted for geriatric, pediatric, infant, and neonatal patients.
  • Convenient A-to-Z format organizes all drug monographs by generic name for quick access to any drug.

Content licensed from printed edition ISBN-10: 0443121109
Content licensed from printed edition ISBN-13: 9780443121104

SUBSCRIPTION:

To access content and available updates, please purchase a yearly auto-renewing subscription.

  • Yearly auto-renewing payments: $49.99

Payment will be charged to your iTunes Account upon confirmation of purchase. Subscription automatically renews unless auto-renew is turned off at least 24 hours before the end of the current period. You can manage your subscription and disable the auto-renewal feature at any time by going to your device settings and tapping "iTunes & App Store." If applicable, any remaining portion of a free trial period will be forfeited upon subscription purchase.

If you have any questions or comments, please email us at customersupport@skyscape.com or call 508-299-3000.

Privacy Policy - https://www.skyscape.com/terms-of-service/privacypolicy.aspx
Terms and Conditions - https://www.skyscape.com/terms-of-service/licenseagreement.aspx

Author(s): Shelly Rainforth Collins, PharmD
Publisher: Elsevier Health Sciences

Genel bakış

IV Medications Elsevier kategori (2) Skyscape Medpresso Inctarafından geliştirilen bir Freeware yazılımdır.

IV Medications Elsevier 5.4.1 05.07.2024 Tarihinde yayımlanan, be. O başlangıçta bizim veritabanı üzerinde 31.01.2024 eklendi.

IV Medications Elsevier aşağıdaki işletim sistemlerinde çalışır: iOS.

Kullanıcılar IV Medications Elsevier 5 dışarı-in 5 yıldız bir puan verdi.

Ekran görüntüsü (tıklayın) büyük görmek için

Güvenli ve ücretsiz indirme UpdateStar tarafından kontrol

Kalış güncel
UpdateStar ile ücretsiz.

Son İncelemeler

ASUS Framework Service ASUS Framework Service
ASUS Framework Service ile ASUS Deneyiminizi Geliştirin
M Microsoft OLE DB Driver for SQL Server
SQL Server için Microsoft OLE DB Sürücüsü ile verimli veri erişimi
Avira Security Avira Security
Avira Security ile Üstün Koruma
N NVIDIA USBC Driver
NVIDIA USBC Sürücüsü ile NVIDIA grafik kartı bağlantınızı optimize edin.
M Mantra Registered Device Service Production
Mantra Kayıtlı Cihaz Hizmeti Üretimi ile Güvenliği Artırın
AnySign4PC AnySign4PC
AnySign4PC ile bilgisayarınızdaki dijital belgeleri zahmetsizce imzalayın!
Güncel Haberler